Treeline Biosciences

About

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Stamford,Connecticut,United States
101 - 250
https://treeline.bio

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $261.26M
Industries: Biotechnology,Health Care,Life Science,Medical
Founded date: Jan 1, 2021
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Treeline Biosciences, Inc.

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

The company was founded in 2021 and is headquartered in Stamford, Connecticut.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

$473.26M

Treeline Biosciences has raised a total of $473.26M in funding over 2 rounds. Their latest funding was raised on Oct 11, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 11, 2022	Series A	$261.26M	5	Kohlberg Kravis Roberts	—	Detail
Apr 27, 2021	Series A	$212M	6	ARCH Venture Partners GV OrbiMed	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

8

Treeline Biosciences is funded by 8 investors. Kohlberg Kravis Roberts and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Kohlberg Kravis Roberts	Yes	Series A
GV	Yes	Series A
Access Industries	—	Series A
ARCH Venture Partners	—	Series A
OrbiMed	—	Series A
Rock Springs Capital	—	Series A
Ajax Health	—	Series A
Casdin Capital	—	Series A